Results 11 to 20 of about 407,106 (256)

Cost-Effectiveness of Physical Rehabilitation and Care of Older Home-Dwelling Persons after Hip Fracture: A Systematic Review and Narrative Synthesis

Journal of Rehabilitation Medicine, 2022
Objective: To provide a systematic review of the literature and knowledge base of cost per quality-adjusted life year of physical rehabilitation and care of older persons after hip fracture.
Jonas Ammundsen Ipsen, Lars T. Pedersen, Eva Draborg , Inge H. Bruun, Charlotte Abrahamsen , Bjarke Viberg   +5 more
doaj   +1 more source

The application of the QALY measure in the assessment of the effects of health interventions on an older population: a systematic scoping review

Archives of Public Health, 2021
Background One of the most commonly used types of evaluation methods is cost-utility analysis (CUA), using the Quality Adjusted Life Year (QALY) indicator as a preference-based measure for assessing effects of a given programme.
Ewa Kocot, Paulina Kotarba, Katarzyna Dubas-Jakóbczyk   +2 more
doaj   +1 more source

Sequencing Systemic Therapy Pathways for Advanced Hepatocellular Carcinoma: A Cost Effectiveness Analysis

Liver Cancer, 2020
Introduction: Hepatocellular carcinoma (HCC) is the most common form of liver cancer worldwide and carries a poor prognosis. Historically, sorafenib was the only available systemic treatment for advanced HCC.
Christopher Sherrow, Kristopher Attwood, Kehua Zhou, Sarbajit Mukherjee, Renuka Iyer, Christos Fountzilas   +5 more
doaj   +1 more source

The effect of surfactant type on characteristics, skin penetration and anti-aging effectiveness of transfersomes containing amniotic mesenchymal stem cells metabolite products in UV-aging induced mice

Drug Delivery, 2022
Transfersome has been developed to enhance dermal delivery of amniotic mesenchymal stem cell metabolite products (AMSC-MP). AMSC-MP contains many growth factors for managing skin aging, thus improving the quality of an adjusted life year. This study aims
Andang Miatmoko, Nurul Ailda Marufah, Qothrin Nada, Noorma Rosita, Tristiana Erawati, Joni Susanto, Kusuma Eko Purwantari, Arif Nurkanto, Purwati  , Widji Soeratri   +9 more
doaj   +1 more source

Methods to Estimate Willingness-to-Pay Per Quality Adjusted Life Year as Cost-Effectiveness Threshold

Jurnal Manajemen dan Pelayanan Farmasi, 2018
Pharmacoeconomic studies, especially the cost-utility analysis method, require a cost-effectiveness threshold for interpretation of the cost-effectiveness ratios of the study. The cost-effectiveness threshold is determined by each country.
Tri Murti Andayani, Dwi Endarti, Susi Ari Kristina, Rifqi Rokhman   +3 more
doaj   +1 more source

Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies

Фармакоэкономика, 2018
The aim was to develop a methodology for determining the willingness to pay threshold (WTPT) and its upper limit value within the Russian health care system.Materials and methods. WTPT was calculated based on the shadow budget price (i. e.
T. S. Teptsova, T. P. Bezdenezhnyh, V. K. Fedyaeva, N. Z Musina, G. R. Hachatryan, V. V. Tarasov   +5 more
doaj   +1 more source

The Estimate of Parental Quality of Life Loss Due to Respiratory Syncytial Virus (RSV) Hospitalization

Diseases, 2023
Background: Respiratory syncytial virus (RSV) is one of the leading causes of pediatric hospitalizations, mainly in children under 2 years of age. Hospitalization affects the caregivers’ quality of life (QoL).
August Wrotek, Oliwia Wrotek, Teresa Jackowska   +2 more
doaj   +1 more source

A technique for approximating transition rates from published survival analyses

Cost Effectiveness and Resource Allocation, 2019
Background Quality-adjusted-life-years (QALYs) are used to concurrently quantify morbidity and mortality within a single parameter. For this reason, QALYs can facilitate the discussion of risks and benefits during patient counseling regarding treatment ...
Markian A. Pahuta, Joel Werier, Eugene K. Wai, Roy A. Patchell, Doug Coyle   +4 more
doaj   +1 more source

QALY losses for chronic diseases and its social distribution in the general population: results from the Belgian Health Interview Survey

BMC Public Health, 2022
Background The burden of chronic diseases is rapidly rising, both in terms of morbidity and mortality. This burden is disproportionally carried by socially disadvantaged population subgroups.
Lisa Van Wilder, Brecht Devleesschauwer, Els Clays, Johan Van der Heyden, Rana Charafeddine, Aline Scohy, Delphine De Smedt   +6 more
doaj   +1 more source

Measuring Quality-Adjusted Life-Years When Health Fluctuates [PDF]

Value in Health, 2020
Recurrent fluctuations in health states can occur as a result of long-term conditions with episodic symptoms or through side effects of cycles of treatment. Fluctuations and associated duration of symptoms can be predictable (eg, side effects of chemotherapy treatment) or unpredictable (eg, relapse in multiple sclerosis). Such recurrent fluctuations in
Sanghera, Sabina, Coast, Joanna
openaire   +4 more sources